Multiple signals converging on NF-κB

Current Opinion in Cell Biology

Volumn 11, Issue 2, 1999, Pages 226-232

  Mercurio, Frank ^a   Manning, Anthony M ^a  

^a CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 1BETA; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

LIMB DEVELOPMENT; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DNA BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0032939903     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80030-1     Document Type: Article

References (50)

1. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 14:1996;649-681.
2. Kopp E., Ghosh S. NF-κB and Rel proteins in innate immunity. Adv Immunol. 58:1995;1-27.
3. Baeuerle P.A., Baltimore D. NF-κB: ten years after. Cell. 87:1996;13-20.
4. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 12:1994;141-179.
5. May M.J., Ghosh S. Signal transduction through NF-κB. Immunol Today. 19:1998;80-88.
6. Whiteside S.T., Epinat J.C., Rice N.R., Israel A. IκB epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16:1997;1413-1426.
7. Henkel T., Zabel U., Van Zee K., Muller J.M., Fanning E., Baeuerle P. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell. 68:1992;1121-1133.
8. Baeuerle P.A., Baichwal V.R. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 65:1997;111-136.
9. Regnier C.H., Song H., Gao H., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
10. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;853-862. First report of the biochemical purification of the IκB kinase complex and the identification of a kinase component responsible for cytokine-inducible phosphorylation of IκB. The authors show that the IKK complex has an apparent relative molecular of greater than 700 kDa and established that its activation kinetics in response to pro-inflammatory cytokines correlates with that of IκB phosphorylation.
11. Zandi E., Rothwarf D.M., Delhasse M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
12. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D., Barbosa M., Mann M., Manning A.M., Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866. Further characterization of the IκB kinase complex, termed the IKK signalsome, and the identification of a second IκB kinase component, termed IKK2. The authors also demonstrated that IKK2 plays a more critical role than IKK1 in the TNFα-mediated activation of the NF-κB signal transduction pathway.
13. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-κ and NIK. Science. 278:1997;866-869.
14. Stancovski I., Baltimore D. NF-κB activation: the IκB kinase revealed? Cell. 91:1997;299-302.
15. Maniatis T. Catalysis by a multiprotein IκB kinase complex. Science. 278:1997;818-819.
16. Verma I.M., Stevenson J. IκB kinase: beginning, not end. Proc Natl Acad Sci USA. 94:1997;11758-11760.
17. Alkalay I., Yaron A., Hatzubai A., Orian A., Ciechanover A., Ben-Neriah Y. Stimulation-dependent IκB phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 92:1995;10599-10603.
18. Yaron A., Gonen H., Alkalay I., Hatzubai A., Jung S., Beyth S., Mercurio F., Manning A.M., Ciechanover A., Ben-Neriah Y. Inhibition of NF-κB cellular function via specific targeting of the IκB ubiquitin ligase. EMBO J. 16:1997;101-107. Elucidation of the mechanism by which phosphorylated IκB is targeted for site-specific ubiquitination and subsequent degradation. The authors precisely defined the ubiquitin ligase substrate recognition motif of the IκBs and demonstrated that introduction of short phosphopeptides based on this motif into cells abrogates stimulus-dependent activation of the NF-κB pathway.
19. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets IκB α to the ubiquitin-proteasome pathway. Genes Dev. 9:1995;1586-1597.
20. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκB α complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222. Identification of mitogen-activated protein kinase kinase kinase-1 as an upstream activator of the IκB kinase complex.
21. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544. Identification of NF-κB-inducing kinase (NIK) as an upstream activator of the IκB kinase complex in response to TNFα, IL-1 and FasL.
22. Ling L., Cao Z., Goeddel D.V. NF-κB-inducing kinase activates IKKα by phosphorylation of Ser176. Proc Natl Acad Sci USA. 95:1998;3792-3797.
23. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., Okumura K. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA. 95:1998;3537-3542.
24. Yin M.J., Christerson L.B., Yamamoto Y., Kwak Y., Xu S., Mercurio F., Barbosa M., Cobb M., Gaynor R. HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell. 93:1998;875-884.
25. Nemoto S., DiDonato J.A., Lin A. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol Cell Biol. 18:1998;7336-7343.
26. O'Connell M.A., Bennett B.L., Mercurio F., Manning A., Mackman N. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem. 273:1998;30410-30414.
27. Yamaoka S., Courtois G., Bessia C., Whiteside S., Weil R., Agou F., Kirk H.E., Kay R.J., Israël A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240. Identification of NF-κB essential modulator NEMO as a non-kinase component of the IκB kinase complex required for efficient activation of IKK2.
28. Mercurio F., Murray B., Bennett B.L., Pascaul G., Shevchenko A., Zhu H., Young D., Li J., Mann M., Manning A. IKKAP-1, a novel regulator of NF-κB activation, reveals heterogeneity in IκB complexes. Mol Cell Biol. 19:1999;1526-1538. Identification and biochemical characterization of distinct IκB kinase complexes, comprised of different IKK dimers, within cells. It was demonstrated that high molecular weight IκBα kinase complexes (greater than 700 kDa) exist in vivo that contain IKK2, but not IKK1, which display TNFα-dependent activation. This finding suggests that IKK1 knock out mice would retain the ability to elicit stimulus-dependent activation of the NF-κB pathway.
29. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300. This work is the first to report the purification and characterization of IKKγ, a core component of the IKK complex. The authors demonstrate that IKKγ directly associates with IKKβ (IKK2) and mediates an essential step in the stimulus-dependent activation of IKK activity.
30. Li Y., Kang J., Horwitz M.S. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor-alpha-inducible cellular protein containing leuine zipper motifs. Mol Cell Biol. 18:1998;1601-1610.
31. Cohen L., Henzel W.J., Baeuerle P.A. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-296.
32. Scherer D.C., Brockman J.A., Chen Z., Maniatis T., Ballard D.W. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc Natl Acad Sci USA. 92:1995;11259-11263.
33. Ciechanover A. The ubiquitin-proteosome pathway: on protein death and cell life. EMBO J. 17:1998;7151-7160.
34. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A., Andersen J., Mann M., Mercurio F., Ben-Neriah Y. Identification of the receptor component of the IκBα- ubiquitin ligase. Nature. 396:1998;590-594.
35. Naumann M., Scheidereit C. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13:1994;4597-4607.
36. Wang D., Baldwin A.S. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J Biol Chem. 273:1998;29411-29416.
37. Zhong H., Yang H.S., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.
38. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
39. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-κB p65 by PKA9stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell. 1:1998;661-671.
40. Manning A. Targeting the NF-κB activation pathway for gene regulating drugs. Curr Opin Drug Disc Dev. 1:1998;147-156.
41. Nusslein-Volhard C., Lohs-Schardin M., Sander K., Cremer C. A dorso-ventral shift embryonic primordia in a new maternal-effect mutant of Drosophila. Nature. 283:1980;474-476.
42. Jiang J., Kosman D., Ip Y.T., Levine M. The dorsal morphogen gradient regulates the mesoderm determinant twist in early Drosophila embryos. Genes Dev. 5:1991;1881-1891.
43. Huang J.D., Schwyter D.H., Shirokawa J.M., Courey A.J. The interplay between multiple enhancer and silencer elements defines the pattern of decapentaplegic expression. Genes Dev. 7:1993;694-704.
44. Chen Z.F., Behringer R.R. Twist is required in head mesenchyme for cranial neural tube morphogensis. Genes Dev. 9:1995;686-699.
45. Howard T.D., Paznekas W.A., Green E.D., Chiang L.C., Ma N., Ortiz de Luna R.I., Garcia Delgado C., Gonzalez Ramos M., Kline A.D., Jabs E.W. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet. 15:1997;36-41.
46. el Ghouzzi V., Le Merrier M., Perrin-Schmildt F., Lajeunie E., Benit P., Renier D., Bourgeois P., Bolcatto-Bellemin A.L., Munich A., Bonaventure A. Mutations of the TWIST, gene in the Saethre-Chotzen syndrome. Nat Genet. 15:1997;42-46.
47. Kanegae Y., Tavares A.T., Izpisua-Belmonte J.C., Verma I. Role of Rel/NF-κB transcription factors during the outgrowth of vertebrate limb. Nature. 392:1998;611-614.
48. Bushdid P., Brantley D., Yull F., Blaeuer G., Hoffman L., Niswander L., Kerr L. Inhibition of NF-κB in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature. 392:1998;615-619.
49. Franzoso G., Carlson L., Xing L., Poljak L., Shores E., Brown K., Leonardi A., Tram T., Boyce B., Siebenlist U. Requirement for NF-κB in oseteoclast and B-cell development. Genes Dev. 11:1997;3482-3496.
50. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., Bravo R. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat Med. 3:1997;1285-1289.